UK start-up Genomics has raised £35mn as it seeks to accelerate the adoption of polygenic risk scores to help people predict and prevent diseases through partnerships with healthcare systems and pharma companies.
The University of Oxford spinout is pushing genetic testing beyond the search for individual genes, looking at how combinations of genes increase people’s likelihood of developing diseases such as cancer or cardiovascular conditions.
您已阅读19%（603字），剩余81%（2525字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。